Skip to main content
SpringerLink
Log in
Book cover

Epigenetic Therapy of Cancer

Preclinical Models and Treatment Approaches

  • Book
  • © 2014

Overview

Editors:
  1. Michael Lübbert

    1. Department of Hematology/Oncology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Peter A. Jones

    1. Norris Comprehensive Cancer Center Urologic Cancer Res. Lab., University of Southern California Dept. Biochemistry & Molecular Biology, Los Angeles, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Devotes detailed attention to the translation of basic research and drug development to clinical applications in the treatment of solid tumors as well as hematologic malignancies and hemoglobinopathy

  • Presents the latest evidence derived from preclinical models regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production

  • Discusses DNA methylation abnormalities in depth

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. The Fundamental Role of Epigenetic Regulation in Normal and Disturbed Cell Growth, Differentiation, and Stemness

    • Manuel Rodríguez-Paredes, Manel Esteller
    Pages 1-41

  3. Mouse Models to Study DNA Methylation in Cancer Research

    • Irina Savelyeva, Frank Rosenbauer
    Pages 43-66

  4. Epigenetic Regulation of Normal Hematopoietic Development

    • Pratima Chaurasia, Dmitriy Berenzon, Ronald Hoffman
    Pages 67-87

  5. Epigenetic Regulation of Globin Genes and Disturbances in Hemoglobinopathies

    • Yogen Saunthararajah, Donald Lavelle, Joseph DeSimone
    Pages 89-106

  6. DNA Methylation Abnormalities in Hematopoietic Disorders: Biological Significance and Methodological Approaches

    • Rainer Claus, Maximilian Schmutz, Gabriele Greve, Lars Bullinger
    Pages 107-120

  7. Epigenetic Modifications Mediated by the AML1/ETO and MLL Leukemia Fusion Proteins

    • Jesús Duque-Afonso, Michael Lübbert, Michael L. Cleary
    Pages 121-144

  8. Treatment of Hematologic Malignancies with DNA Hypomethylating Agents

    • Michael Daskalakis, Tina E. Joeckel, Michael Lübbert, A. Kuendgen
    Pages 145-170

  9. Pharmacodynamic Responses to DNA Methyltransferase Inhibition

    • Elizabeth Griffiths, Richard L. Momparler, Adam R. Karpf
    Pages 171-188

  10. Histone Methyltransferases: Opportunities in Cancer Drug Discovery

    • Richard Chesworth, Tim J. Wigle, Kevin W. Kuntz, Jesse J. Smith, Victoria M. Richon
    Pages 189-226

  11. Histone Deacetylase (HDAC) Inhibitors in Recent Clinical Trials for Cancer Therapy

    • Kristina Keller, Manfred Jung
    Pages 227-255

  12. Clinical Implications of Epigenetic Alterations in Lung Cancer

    • David S. Schrump
    Pages 257-282

  13. Epigenetic Disturbances in Colorectal Cancer

    • Sarah Derks, Manon van Engeland
    Pages 283-298

  14. Epigenetic Therapies in Solid Tumours: From Preclinical Models to Clinical Trial Results

    • Robert Brown, Juliane Steinmann, Janet Graham, Ros Glasspool
    Pages 299-317

  15. Back Matter

    Pages 319-325
    Download chapter PDF
Back to top

Keywords

About this book

The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.

Reviews

From the reviews:

“This new book covers the timely topic of epigenetic therapy. … The combination of articles describing the basic science framework of epigenetics and the detailed summaries of clinical trials with epigenetic drugs is attractive for a wide readership, ranging from medical students to scientists who are interested in translational studies to clinicians who work for the direct benefit of cancer patients. … This high-quality book is an excellent overview of the current success and future promise of epigenetic therapy.” (Gerd Pfeifer, Doody’s Book Reviews, May, 2014)

Editors and Affiliations

  • Department of Hematology/Oncology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany

    Michael Lübbert

  • Norris Comprehensive Cancer Center Urologic Cancer Res. Lab., University of Southern California Dept. Biochemistry & Molecular Biology, Los Angeles, USA

    Peter A. Jones

Bibliographic Information

  • Book Title: Epigenetic Therapy of Cancer

  • Book Subtitle: Preclinical Models and Treatment Approaches

  • Editors: Michael Lübbert, Peter A. Jones

  • DOI: https://doi.org/10.1007/978-3-642-38404-2

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2014

  • Hardcover ISBN: 978-3-642-38403-5Published: 15 January 2014

  • Softcover ISBN: 978-3-662-51928-8Published: 24 September 2016

  • eBook ISBN: 978-3-642-38404-2Published: 12 December 2013

  • Edition Number: 1

  • Number of Pages: X, 325

  • Number of Illustrations: 34 b/w illustrations, 14 illustrations in colour

  • Topics: Oncology, Hematology, Gene Therapy

Publish with us

Policies and ethics

Back to top

Search

Navigation